November 26, 2025
Recce Pharmaceuticals (ASX:RCE) reports positive efficacy data for inhaled R327
Recce Pharmaceuticals has reported new preclinical data showing that inhaled RECCE 327 achieved strong antibacterial activity against carbapenem resistant Acinetobacter baumannii in validated pneumonia models.